SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Liabilities (Quarterly) : 7.726M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.726M |
| March 31, 2026 | 6.765M |
| December 31, 2025 | 7.474M |
| September 30, 2025 | 5.925M |
| June 30, 2025 | 6.156M |
| March 31, 2025 | 7.197M |
| December 31, 2024 | 10.17M |
| September 30, 2024 | 10.61M |
| June 30, 2024 | 12.21M |
| March 31, 2024 | 14.75M |
| December 31, 2023 | 14.38M |
| September 30, 2023 | 11.91M |
| June 30, 2023 | 13.72M |
| March 31, 2023 | 15.94M |
| December 31, 2022 | 16.28M |
| September 30, 2022 | 13.40M |
| June 30, 2022 | 13.15M |
| March 31, 2022 | 17.41M |
| December 31, 2021 | 6.08M |
| September 30, 2021 | 11.34M |
| June 30, 2021 | 10.21M |
| March 31, 2021 | 11.83M |
| December 31, 2020 | 19.23M |
| September 30, 2020 | 10.56M |
| June 30, 2020 | 10.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.964M |
| December 31, 2019 | 10.52M |
| September 30, 2019 | 10.85M |
| June 30, 2019 | 10.70M |
| March 31, 2019 | 11.98M |
| December 31, 2018 | 13.10M |
| September 30, 2018 | 20.01M |
| June 30, 2018 | 34.46M |
| March 31, 2018 | 34.80M |
| December 31, 2017 | 31.46M |
| September 30, 2017 | 34.96M |
| June 30, 2017 | 41.43M |
| March 31, 2017 | 43.14M |
| December 31, 2016 | 37.15M |
| September 30, 2016 | 48.92M |
| June 30, 2016 | 53.46M |
| March 31, 2016 | 53.95M |
| December 31, 2015 | 68.63M |
| September 30, 2015 | 50.25M |
| June 30, 2015 | 52.60M |
| March 31, 2015 | 49.52M |
| December 31, 2014 | 43.43M |
| September 30, 2014 | 48.63M |
| June 30, 2014 | 51.96M |
| March 31, 2014 | 45.79M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Savara, Inc. | 48.48M |
| Lite Strategy, Inc. | 0.952M |
| AbbVie, Inc. | 141.00B |
| Marker Therapeutics, Inc. | 2.42M |
| Rezolute, Inc. | 8.625M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.38M |
| Shareholders Equity (Quarterly) | 137.66M |
| Debt to Equity Ratio | 0.0054 |
| Current Ratio | 18.83 |
| Net Debt Paydown Yield | 0.00% |